Rx Safety Communication In Face Of Uncertainty, Multiple Risks, To Be Examined By FDA Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Risk Communication Advisory Committee will delve into research on communicating uncertainty and how individuals perceive risk and seek information when confronted with multiple risks, during a June 29 meeting.